作者：
Yarchoan,M. [1]
;
Louneva,N. [2]
;
Xie,S.X. [3]
;
Swenson,F.J. [4]
;
Hu,W. [5]
;
Soares,H. [6]
;
Trojanowski,J.Q. [7]
;
Lee,V.M.-Y. [8]
;
Kling,M.A. [9]
;
Shaw,L.M. [10]
;
Chen-Plotkin,A. [11]
;
Wolk,D.A. ;
Arnold,S.E.
作者单位：
Pfizer Global Research and Development, Groton, CT, United States
[1]
Behavioral Health Service, Philadelphia VA Medical Center, Philadelphia, PA, United States
[2]
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
[3]
Departments of Psychiatry and Neurology, University of Pennsylvania, Philadelphia, PA, United States
[4]
Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, United States
[5]
Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, United
[6]
Emory Alzheimer's Disease Research Center, Emory University, Atlanta, GA, United States
[7]
Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia PA, United
[8]
Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA, United States
[9]
Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States
[10]
Pfizer Diagnostics, PharmaTX Precision Medicine, Groton, CT, United States
[11]
发布时间
2014-01-24
换一批
